UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015461
Receipt No. R000017957
Official scientific title of the study Feasibility study on detecting EGFR T790M mutation in cell free DNA from advanced non small cell lung cancer patients refractory to EGFR-TKI:WJOG8014LTR
Date of disclosure of the study information 2014/10/17
Last modified on 2018/03/13 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Feasibility study on detecting EGFR T790M mutation in cell free DNA
from advanced non small cell lung cancer patients refractory to EGFR-TKI:WJOG8014LTR
Title of the study (Brief title) Feasibility study on detecting EGFR T790M mutation in cell free DNA
from advanced non small cell lung cancer patients refractory to EGFR-TKI
Region
Japan

Condition
Condition Advanced non-small cell lung cancer with EGFR mutation
Classification by specialty
Pneumology Hematology and clinical oncology
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 To evaluate the procedure for detecting EGFR T790M mutation in cell free DNA from advanced non small cell lung cancer patients refractory to EGFR-TKI
Basic objectives2 Others
Basic objectives -Others o evaluate the feasibility of detecting EGFR T790M mutation in cell free DNA from advanced non-small cell lung cancer patients
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes feasibility of detecting EGFR T790M mutation in cell free DNA
from advanced non small cell lung cancer patients refractory to EGFR-TKI
Key secondary outcomes detection rate of EGFR T790M mutations in plasma
concordance of EGFR mutation status between tissue sample and plasma
correlation between EGFR mutation status and clinical background

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) advanced non-small cell lung cancer harboring EGFR mutations
2) refractory to EGFR-TKI monotherapy or combination therapy
* accept patients receiving EGFR-TKI therapy beyond PD with or without local therapy such as radiation therapy for brain or bone metastasis
3) written informed consent obtained from the patient
Key exclusion criteria Not applicable
Target sample size 155

Research contact person
Name of lead principal investigator Kazuto Nishio
Organization Kinki University
Division name Faculty of Medicine, Dept. of Genome Biology
Address 377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511
TEL 072-366-0221
Email knishio@med.kindai.ac.jp

Public contact
Name of contact person Shinichiro Nakamura
Organization West Japan Oncology Group
Division name datacenter
Address Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku,Osaka 556-0016 JAPAN
TEL 06-6633-7400
Homepage URL
Email datacenter@wjog.jp

Sponsor
Institute West Japan Oncology Group
Institute
Department

Funding Source
Organization Astellas Pharma Inc.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Kinki University Faculty of Medicine, Dept. of Genome Biology
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 17 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 09 Month 14 Day
Anticipated trial start date
2014 Year 11 Month 04 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results https://www.ncbi.nlm.nih.gov/pubmed/27542267
Results
Other related information Nothing particular

Management information
Registered date
2014 Year 10 Month 17 Day
Last modified on
2018 Year 03 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017957